182 related articles for article (PubMed ID: 22118630)
1. Proinsulin, GLP-1, and glucagon are associated with partial remission in children and adolescents with newly diagnosed type 1 diabetes.
Kaas A; Andersen ML; Fredheim S; Hougaard P; Buschard K; Petersen JS; de Beaufort C; Robertson KJ; Hansen L; Mortensen HB; Nielsen LB;
Pediatr Diabetes; 2012 Feb; 13(1):51-8. PubMed ID: 22118630
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic beta-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetes.
Asmar M; Højberg PV; Deacon CF; Hare K; Holst JJ; Madsbad S
Regul Pept; 2010 Feb; 160(1-3):175-80. PubMed ID: 20005261
[TBL] [Abstract][Full Text] [Related]
3. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
Cuthbertson J; Patterson S; O'Harte FP; Bell PM
Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
[TBL] [Abstract][Full Text] [Related]
4. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
5. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
Dupre J
Regul Pept; 2005 Jun; 128(2):149-57. PubMed ID: 15780434
[TBL] [Abstract][Full Text] [Related]
6. C-peptide in the classification of diabetes in children and adolescents.
Ludvigsson J; Carlsson A; Forsander G; Ivarsson S; Kockum I; Lernmark A; Lindblad B; Marcus C; Samuelsson U
Pediatr Diabetes; 2012 Feb; 13(1):45-50. PubMed ID: 21910810
[TBL] [Abstract][Full Text] [Related]
7. Proinsulin associates with poor β-cell function, glucose-dependent insulinotropic peptide, and insulin resistance in persistent type 2 diabetes after Roux-en-Y gastric bypass in humans.
Patel K; Levesque K; Mark V; Pierini E; Rojas B; Ahlers M; Shah A; Laferrère B
J Diabetes; 2020 Jan; 12(1):77-86. PubMed ID: 31245904
[TBL] [Abstract][Full Text] [Related]
8. Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide.
Thivolet C; Marchand L; Chikh K
Diabetologia; 2019 Apr; 62(4):593-597. PubMed ID: 30612138
[TBL] [Abstract][Full Text] [Related]
9. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.
Todd JF; Edwards CM; Ghatei MA; Mather HM; Bloom SR
Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852
[TBL] [Abstract][Full Text] [Related]
11. [The insulin and proinsulin levels in patients with newly detected diabetes mellitus].
Arbuzova MI; Lobanova AM; Smirnova OM; Antsiferov MB; Starostina EG
Probl Endokrinol (Mosk); 1989; 35(5):28-31. PubMed ID: 2685803
[TBL] [Abstract][Full Text] [Related]
12. Smoking and other factors associated with short-term partial remission of Type 1 diabetes in adults.
Pilacinski S; Adler AI; Zozulinska-Ziolkiewicz DA; Gawrecki A; Wierusz-Wysocka B
Diabet Med; 2012 Apr; 29(4):464-9. PubMed ID: 21978224
[TBL] [Abstract][Full Text] [Related]
13. Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus.
Hillman M; Eriksson L; Mared L; Helgesson K; Landin-Olsson M
J Cyst Fibros; 2012 Mar; 11(2):144-9. PubMed ID: 22138561
[TBL] [Abstract][Full Text] [Related]
14. Abnormal proinsulin/C-peptide ratio in juvenile diabetes.
Ludvigsson J; Heding L
Acta Diabetol Lat; 1982; 19(4):351-8. PubMed ID: 6758459
[TBL] [Abstract][Full Text] [Related]
15. A comparison of glycemic parameters and their relationship with C-peptide and Proinsulin levels during partial remission and non-remission periods in children with type 1 diabetes mellitus - a cross-sectional study.
Yeşiltepe-Mutlu G; Çapacı M; Can E; Gökçe T; Bayrakçı G; Muradoğlu S; İncir S; Çakır EP; Hatun Ş
BMC Endocr Disord; 2021 Jan; 21(1):18. PubMed ID: 33485357
[TBL] [Abstract][Full Text] [Related]
16. Proinsulin levels and the proinsulin:c-peptide ratio complement autoantibody measurement for predicting type 1 diabetes.
Truyen I; De Pauw P; Jørgensen PN; Van Schravendijk C; Ubani O; Decochez K; Vandemeulebroucke E; Weets I; Mao R; Pipeleers DG; Gorus FK;
Diabetologia; 2005 Nov; 48(11):2322-9. PubMed ID: 16211374
[TBL] [Abstract][Full Text] [Related]
17. Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes.
Pörksen S; Nielsen LB; Kaas A; Kocova M; Chiarelli F; Orskov C; Holst JJ; Ploug KB; Hougaard P; Hansen L; Mortensen HB;
J Clin Endocrinol Metab; 2007 Aug; 92(8):2910-6. PubMed ID: 17519307
[TBL] [Abstract][Full Text] [Related]
18. Proinsulin to C-Peptide Ratio in the First Year After Diagnosis of Type 1 Diabetes.
Freese J; Al-Rawi R; Choat H; Martin A; Lunsford A; Tse H; Mick G; McCormick K
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4318-e4326. PubMed ID: 34228132
[TBL] [Abstract][Full Text] [Related]
19. Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults.
Schölin A; Nyström L; Arnqvist H; Bolinder J; Björk E; Berne C; Karlsson FA;
Diabet Med; 2011 Feb; 28(2):156-61. PubMed ID: 21219422
[TBL] [Abstract][Full Text] [Related]
20. Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus.
Snorgaard O; Hartling SG; Binder C
Diabetologia; 1990 Jan; 33(1):36-42. PubMed ID: 2303172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
